Trissel Lawrence A, Trusley Craig, Ben Michel, Kupiec Thomas C
TriPharma Research, Cashiers, NC 28717-0265, USA.
Am J Health Syst Pharm. 2007 Jun 1;64(11):1209-13. doi: 10.2146/ajhp060355.
The physical and chemical compatibility of palonosetron hydrochloride with fentanyl citrate, hydromorphone hydrochloride, meperidine hydrochloride, morphine sulfate, and sufentanil citrate during simulated Y-site administration was studied.
Test samples were prepared in triplicate by mixing 7.5-mL samples of undiluted palonosetron 50 microg/mL (of palonosetron) with 7.5-mL samples of fentanyl citrate 50 microg/mL, morphine sulfate 15 mg/mL, hydromorphone hydrochloride 0.5 mg/mL, meperidine hydrochloride 10 mg/mL, and sufentanil citrate 12.5 microg/mL (of sufentanil) per milliliter individually in colorless 15-mL borosilicate glass screw-cap culture tubes with polypropylene caps. Physical stability of the admixtures was assessed by visual examination and by measuring turbidity and particle size and content. Chemical stability was assessed by stability-indicating high-performance liquid chromatography. Evaluations were performed immediately and one and four hours after mixing.
All of the admixtures were initially clear and colorless in normal fluorescent room light and when viewed with a high-intensity monodirectional light (Tyndall beam) and were essentially without haze. Changes in turbidity were minor throughout the study. Particulates measuring 10 microm or larger were few in all samples throughout the observation period. The admixtures remained colorless throughout the study. No loss of palonosetron hydrochloride occurred with any of the opiate agonists tested over the four-hour period. Similarly, little or no loss of the opiate agonists occurred over the four-hour period.
Palonosetron hydrochloride was physically and chemically stable with fentanyl citrate, hydromorphone hydrochloride, meperidine hydrochloride, morphine sulfate, and sufentanil citrate during simulated Y-site administration.
研究在模拟Y型接口给药过程中,盐酸帕洛诺司琼与枸橼酸芬太尼、盐酸氢吗啡酮、盐酸哌替啶、硫酸吗啡和枸橼酸舒芬太尼的物理和化学相容性。
通过将7.5 mL未稀释的50 μg/mL(以帕洛诺司琼计)盐酸帕洛诺司琼样品与7.5 mL 50 μg/mL枸橼酸芬太尼、15 mg/mL硫酸吗啡、0.5 mg/mL盐酸氢吗啡酮、10 mg/mL盐酸哌替啶和12.5 μg/mL(以舒芬太尼计)枸橼酸舒芬太尼样品分别在带有聚丙烯帽的15 mL无色硼硅酸盐玻璃螺帽培养管中混合,一式三份制备测试样品。通过目视检查、测量浊度、粒径和含量来评估混合物的物理稳定性。通过稳定性指示高效液相色谱法评估化学稳定性。在混合后立即、1小时和4小时进行评估。
在正常荧光室内光线下以及用高强度单向光(廷德尔光束)观察时,所有混合物最初均清澈无色,基本无雾。在整个研究过程中,浊度变化很小。在整个观察期内,所有样品中测量到的10微米或更大的颗粒很少。在整个研究过程中,混合物保持无色。在4小时期间,与任何测试的阿片类激动剂混合时,盐酸帕洛诺司琼均未损失。同样,在4小时期间,阿片类激动剂的损失很少或没有损失。
在模拟Y型接口给药过程中,盐酸帕洛诺司琼与枸橼酸芬太尼、盐酸氢吗啡酮、盐酸哌替啶、硫酸吗啡和枸橼酸舒芬太尼在物理和化学上是稳定的。